Peer-reviewed veterinary case report
Stem cell extract treatment for canine pancreatitis and inflammation
By Choi, Yongsoo et al.·Published in Frontiers in veterinary science·2025·Yong Animal CTMRI Medical Center, South Korea·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Treatment of canine pancreatitis using membrane-free stem cell extract and its anti-inflammatory effect.
- Species:
- dog
Plain-English summary
A group of 145 dogs with pancreatitis, a painful condition that can lead to serious complications, were treated to see if a new therapy could help. Some dogs received a special treatment called membrane-free stem cell extract (MF-STEM) along with standard care, while others only got the standard care. The results showed that 92% of the dogs receiving MF-STEM survived, compared to only 46% in the control group. This suggests that MF-STEM may help reduce inflammation and improve survival rates in dogs with pancreatitis, and there were no side effects reported.
People also search for: dog pancreatitis treatment · stem cell therapy for dogs · pancreatitis survival rate in dogs
Abstract
Canine pancreatitis can lead to the digestion of nearby organs, and if untreated, it can develop into peritonitis. Widely used treatment as of now for acute pancreatitis (AP), however, largely depends on supportive treatment such as fluid therapy, antibiotics, and sufficient nutrient intake. Membrane-free stem cell extract (MF-STEM) is a protein mixture and other bioactive molecules derived from human adipose stem cells. MF-STEM is known for its anti-inflammatory and regenerative effects. This study was a vehicle-controlled clinical study. One hundred and forty-five canine pancreatitis patients with pancreatitis participated in this study with owners' consent. Following the owners' consent, 63 dogs received MF-STEM cell therapy with conventional therapy, and 82 dogs received conventional therapy. All participants had their cPL and CRP measured to evaluate their clinical progression. At the time of discharge, the survival rate in the MF-STEM cell therapy group survived (survival 92% and mortality 8%) more than the control group (survival 46% and mortality 54%). The authors suppose that MF-STEM cell increases survival of pancreatitis patients by modulating inflammatory cytokines. There were no side effects observed, such as allergic reactions and hypersensitivity reactions.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/40524736/